Correlation Between CEL SCI and Ayala Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both CEL SCI and Ayala Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CEL SCI and Ayala Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CEL SCI Corp and Ayala Pharmaceuticals, you can compare the effects of market volatilities on CEL SCI and Ayala Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CEL SCI with a short position of Ayala Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of CEL SCI and Ayala Pharmaceuticals.

Diversification Opportunities for CEL SCI and Ayala Pharmaceuticals

0.19
  Correlation Coefficient

Average diversification

The 3 months correlation between CEL and Ayala is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding CEL SCI Corp and Ayala Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ayala Pharmaceuticals and CEL SCI is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CEL SCI Corp are associated (or correlated) with Ayala Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ayala Pharmaceuticals has no effect on the direction of CEL SCI i.e., CEL SCI and Ayala Pharmaceuticals go up and down completely randomly.

Pair Corralation between CEL SCI and Ayala Pharmaceuticals

If you would invest  61.00  in CEL SCI Corp on September 28, 2024 and sell it today you would earn a total of  9.00  from holding CEL SCI Corp or generate 14.75% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy5.0%
ValuesDaily Returns

CEL SCI Corp  vs.  Ayala Pharmaceuticals

 Performance 
       Timeline  
CEL SCI Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days CEL SCI Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Ayala Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ayala Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Ayala Pharmaceuticals is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

CEL SCI and Ayala Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with CEL SCI and Ayala Pharmaceuticals

The main advantage of trading using opposite CEL SCI and Ayala Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CEL SCI position performs unexpectedly, Ayala Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ayala Pharmaceuticals will offset losses from the drop in Ayala Pharmaceuticals' long position.
The idea behind CEL SCI Corp and Ayala Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Other Complementary Tools

Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios